Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

Company

Rius Medical

Rius Medical_logo
35
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Rius Medical mission is to make its proprietary highly innovative platform available at year 2 to pharmaceutical and biotech partners - Proprietary cell lines for drug delivery. Engineer stem cells for next generation therapeutics as core business.

Waldachtal, Baden-Württemberg, Germany

Send a message

Anglais

Rius Medical

Anglais

The Elevator Pitch: Rius Medical is developing Advanced Manufacturing to help patients with cancer and other diseases, like type 1 diabetes by solving the problem of Drug Delivery through reprogramming stem cells.

 

On offer as Business-to-Business solution to France-based Erytech Pharma, Switzerland-based Orphan Technologies among others is upgraded red blood cells that do more than simply carry oxygen. For example...

See more

The Elevator Pitch: Rius Medical is developing Advanced Manufacturing to help patients with cancer and other diseases, like type 1 diabetes by solving the problem of Drug Delivery through reprogramming stem cells.

 

On offer as Business-to-Business solution to France-based Erytech Pharma, Switzerland-based Orphan Technologies among others is upgraded red blood cells that do more than simply carry oxygen. For example Erytech Pharma’s therapeutic product (half-life 29 days) is undergoing clinical Phase III for pancreatic cancer and clinical Phase II for breast cancer. The Business Model is that of a provider/supplier of 120 days lifespan red blood cells against blood donation half-life 29 days red blood cells.

 

Rius Medical is seeking a 400,000 euro bridge financing for early start July 2021 onwards instead of December 2021 under EIC Pathfinder OPEN grant – supporting the exploration of bold ideas for radically new technologies. Rius Medical proposal has a convincing long-term vision of a radically new technology with a transformative positive effect to the economy and society.

 

An EXIT opportunity at year 2 for early investors joining this Series A investment round of up to 1 million euro and post-money valuation at 5 million euro will result in EUR 10,5 million financial benefits on TWO products at year 2. So 400,000 euro bridge financing against 8% ownership results in EUR 4,2 million financial benefits on TWO products by December 2022!

  • 6

    Followers

  • 1

    Like

Our latest news

Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2667 Members
ESIL - Early Stage Investing Launchpad
A pan-european community to develop awareness-raising and capacity-building for business angels and other early-stage investors.
469 Members

Our history

Start in 31 August 2016

  • 31 August 2016

    registration with the commercial register of Stuttgart local court under folio HRB 757947

to be continued ...